These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 38542332)

  • 21. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
    Toiyama Y; Okugawa Y; Goel A
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer epigenetics: complex simplicity.
    van Engeland M; Derks S; Smits KM; Meijer GA; Herman JG
    J Clin Oncol; 2011 Apr; 29(10):1382-91. PubMed ID: 21220596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation of aberrant DNA methylation during colorectal cancer development.
    Sakai E; Nakajima A; Kaneda A
    World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis.
    Ajithkumar P; Vasantharajan SS; Pattison S; McCall JL; Rodger EJ; Chatterjee A
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of epigenetics in transformation of inflammation into colorectal cancer.
    Yang ZH; Dang YQ; Ji G
    World J Gastroenterol; 2019 Jun; 25(23):2863-2877. PubMed ID: 31249445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine.
    Fatemi N; Tierling S; Es HA; Varkiani M; Mojarad EN; Aghdaei HA; Walter J; Totonchi M
    Int J Cancer; 2022 Dec; 151(12):2068-2081. PubMed ID: 35730647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic-based therapy for colorectal cancer: Prospect and involved mechanisms.
    Rezapour S; Hosseinzadeh E; Marofi F; Hassanzadeh A
    J Cell Physiol; 2019 Nov; 234(11):19366-19383. PubMed ID: 31020647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.
    Zoratto F; Rossi L; Verrico M; Papa A; Basso E; Zullo A; Tomao L; Romiti A; Lo Russo G; Tomao S
    Tumour Biol; 2014 Jul; 35(7):6195-206. PubMed ID: 25051912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug resistance in colorectal cancer: An epigenetic overview.
    Luo M; Yang X; Chen HN; Nice EC; Huang C
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188623. PubMed ID: 34481016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
    Gezer U; Holdenrieder S
    In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers.
    Zabeti Touchaei A; Vahidi S; Samadani AA
    Clin Exp Med; 2024 Jan; 24(1):29. PubMed ID: 38294554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges.
    Vaiopoulos AG; Athanasoula KCh; Papavassiliou AG
    Biochim Biophys Acta; 2014 Jul; 1842(7):971-80. PubMed ID: 24561654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance.
    Zhao N; Lai C; Wang Y; Dai S; Gu H
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189096. PubMed ID: 38499079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of epigenetic modifications in Colorectal Cancer Metastasis.
    Su R; Wu X; Tao L; Wang C
    Clin Exp Metastasis; 2022 Aug; 39(4):521-539. PubMed ID: 35429301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer.
    Grady WM
    Adv Cancer Res; 2021; 151():425-468. PubMed ID: 34148620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetics of colorectal cancer.
    Yan W; Guo M
    Methods Mol Biol; 2015; 1238():405-24. PubMed ID: 25421673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.
    Gyparaki MT; Basdra EK; Papavassiliou AG
    J Mol Med (Berl); 2013 Nov; 91(11):1249-56. PubMed ID: 24057814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.